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Background: The functions of free radicals on the effects of insulin that result in protection against cerebral ischemic
insult in diabetes remain undefined. This present study aims to explain the contradiction among nitric oxide
(NO)/superoxide/peroxynitrite of insulin in amelioration of focal cerebral ischemia–reperfusion (FC I/R) injury in
streptozotocin (STZ)-diabetic rats and to delineate the underlying mechanisms. Long-Evans male rats were divided
into three groups (age-matched controls, diabetic, and diabetic treated with insulin) with or without being subjected
to FC I/R injury.
Results: Hyperglycemia exacerbated microvascular functions, increased cerebral NO production, and aggravated
FC I/R-induced cerebral infarction and neurological deficits. Parallel with hypoglycemic effects, insulin improved
microvascular functions and attenuated FC I/R injury in STZ-diabetic rats. Diabetes decreased the efficacy of NO and
superoxide production, but NO and superoxide easily formed peroxynitrite in diabetic rats after FC I/R injury. Insulin
treatment significantly rescued the phenomenon.
Conclusions: These results suggest that insulin renders diabetic rats resistant to acute ischemic stroke by arresting
NO reaction with superoxide to form peroxynitrite.
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The principal mediator of cerebral injury secondary to
ischemic stroke is oxidative stress [1]. Oxidative stress-
mediated cerebral injury is the consequence of an imbal-
ance between free radical generation and elimination
due to increased reactive oxygen and nitrogen species
generation and inadequate antioxidant defense [1]. Cen-
tral nervous system cells are more vulnerable to oxidative
stress given their inherent higher oxidative metabolism
and less antioxidant enzymes and higher membranous
fatty acid content. During ischemic stroke, the free radicals
concentration rises from normal low levels to a peak point
during reperfusion, possibly underlying apoptosis or cellu-
lar necrosis. Malinski et al. found that the basal nitric* Correspondence: sshuang@csmu.edu.tw
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unless otherwise stated.oxide (NO) levels are in the nanomolar range, neverthe-
less, the amount rapidly increases to micromolar levels
following cerebral ischemia [1,2]. The cerebral ischemia
reperfusion injury can also increase superoxide production
[3]. In addition, increasing evidence in both experimental
and clinical studies also suggests that oxidative stress is
critical in the pathogenesis of both types of diabetes melli-
tus [4]. However, studies of diabetic NO levels have yielded
conflicting results. Some investigators have demonstrated
impaired NO production in diabetes [5,6]. By contrast,
other studies have observed increased NO in diabetes [7]
or no change in NO level in the diabetic state [8].
In the basic studies, insulin treatment protects neuro-
logical function following cerebral ischemia in hypergly-
cemic rats [9,10]. However, the roles of free radicals on
the effects of insulin that result in protection against
cerebral ischemic insult in diabetes remain undefined.
The primary aim of the present study is to resolve thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ondary aim is to explore the possible mechanisms (with
specific focus on NO/superoxide/peroxynitrite) of insu-
lin in amelioration of focal cerebral ischemia-reperfusion
(FC I/R) injury in streptozotocin (STZ)-diabetic rats.
Methods
Experimental animals
Healthy adult male Long-Evans rats (National Lab. Animal
Breeding and Research Center) were used throughout this
study and were maintained in the Animal Center of the
Chang Gung University, at an ambient temperature of
25 ± 1°C and a light-dark period of 12 h. The animals
were fed with normal chow and water. This investi-
gation abides by the rules in the Guide for the Care
and Use of Laboratory Animals published by the US
National Institutes of Health (NIH publication no. 85-23,
revised 1996).
Induction of STZ-diabetic animal model
Diabetes was induced according to the previous-described
protocol [11]. The experimental animals were randomly di-
vided into two groups: (1) age-matched non-diabetic con-
trol (Con) and (2) STZ-induced diabetic rats (DM). The
animals were then injected with a single intravenous injec-
tion of vehicle (normal saline) or freshly prepared STZ
(65 mg/kg). The STZ-diabetic animals were further ran-
domly divided into two groups: (1) DM and (2) diabetic
rats treated with insulin (DMI; Monotard® HM; Novo
Nordisk, Bagsvaerd, Denmark).STZ-diabetic rats were
subcutaneously injected with insulin (4 IU/rat/day) for 1
week (at 8 to 9 AM from days 15 to 21 of STZ injection).
The animals were subjected to FC I/R injury at 8 AM on
day 22.
Surgical procedure and analysis of infarct volume
Focal ischemic infarcts were carried out by operation as
reported previously with some modifications [12]. In
brief, rats weighing between 250 g and 280 g were anes-
thetized with chlorohydrate (4.5 mg/kg, intraperitoneal
injection) after 24 h of the last vehicle (normal saline) or
insulin treatment. Rectal temperature was monitored and
kept constant (37 ± 0.5°C) during the surgical procedure
and recovery period. The animals were performed crani-
otomy at the junction of the zygoma and squamosal bone
using a drill (Dremel Multipro + 5395, Dremel com.
USA) and the dura was opened with fine forceps using a
dissecting microscope (OPMI-1, ZISS, Germany). The
right middle cerebral artery (MCA) was ligated with 10-0
monofilament nylon ties and both common carotid arter-
ies were then occluded by microaneurysm clips for 1 h.
After removing the clips, return of blood flow was visual-
ized in both common carotid arteries. However, the right
MCA ligature was left in place permanently [13].Animals were sacrificed by rapid decapitation under
deep anesthesia. Brains were rapidly removed and sliced
into 2-mm thick coronal sections using a brain matrix
slicer (JACOBOWITZ Systems, Zivic-Miller Laboratories
INC, Allison park, USA) and stained with 2,3,5-triphenyl-
tetrazolium chloride (TTC; 2%; Sigma-Aldrich, USA) at
37°C and kept in the dark for 30 min, followed by fixation
with 10% formalin at room temperature overnight. The in-
farcted tissue, clearly visible by a lack of TTC staining [14],
was outlined on the posterior surface of each slice using an
image analyzer (color image scanner, EPSON GT-9000),
connected to an image analysis system (AIS software, Im-
aging research INC, Canada) run on a personal computer,
AMD K6-2 3D 400. Infarct volume was obtained as the
sum of infarct area per slice multiplied by slice thickness.
The infarct volume was expressed as volume (mm3) of the
whole brain. Both the surgeon and image analyzer operator
were blinded to the treatment of each animal.
Assessment of neurological functions
The modified Bederson score [15] was used 24 h after
FC I/R injury to determine global neurological function
based on the following scoring system: 0, no deficit; 1,
forelimb flexion; 2, decreased resistance to lateral push;
3, unidirectional circling; 4, longitudinal spinning; and 5,
no movement.
Biochemical analysis
Blood was collected from the tail vein for biochemical
measurements in experimental rats. Plasma was used for
the measurements of total cholesterol and triglyceride
(Randox reagent kits, Randox Laboratories LTD. Antrim,
United Kingdom). Insulin was measured using a com-
mercial available kit provided by Mercodia (rat insulin
ELISA kit, Uppsala, Sweden). Blood glucose levels were
determined by the glucose oxidase method (ChemWell ®
2910 Automated EIA and Chemistry Analyzer Spectra,
GMI Inc., USA). The NO/ozone chemiluminescence
technique (NOA 280; Sievers Instruments; Boulder, CO,
USA) was employed for measuring cerebral NO levels.
The deproteinized tissue samples were isolated from
brain in accordance to previously published procedures
with slight modifications [16]. Superoxide production
was measured from the cerebrum by lucigenin-enhanced
chemiluminescence, using previously described and vali-
dated methods [17]. Peroxynitrite production from the
cerebrum of different groups of rats was measured by
the luminol-enhanced chemiluminescence method as de-
scribed previously [18].
Intravital microscopic observation of cremasteric
microciculation
The cremaster muscle was prepared for intravital mi-
croscopy following methods reported previously [19].
Table 1 Laboratory characteristics in age-matched non-
diabetic control (Con), diabetic (DM), and insulin-treated
diabetic (DMI) rats before and after FC I/R-injury
Con (n = 10) DM (n = 10) DMI (n = 10)
Body weight (g) 391 ±7 292 ± 11* 329 ± 14†
Before FC I/R-injury
Plasma glucose (mg/dl) 125 ± 5 460± 15* 153 ± 10†
Plasma insulin (μg/L) 2.58 ± 0.36 0.56 ± 0.07* 2.04 ± 0.55†
After FC I/R-injury
Plasma glucose (mg/dl) 194 ± 7 508 ± 43* 350 ± 51†
Plasma insulin (μg/L) 3.07 ± 0.36 0.61 ± 0.10* 1.66 ± 0.41†
Data are expressed as mean ± SEM (*P < 0.05 vs. control, †P < 0.05 vs. DM).
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(65 mg/kg, i.p.) and surgical exposure of the cremaster
muscle. The cremasteric microcirculation was visualized
using an intravital microscope (Nikon Measurescope
MM-22, Tokyo, Japan). A digital camera (Sony DXC-750
MD, Tokyo, Japan) was adapted between intravital micro-
scope and a videocassette recorder (Sony SVO-9600,
Tokyo, Japan) and project the images onto a calibrated
monitor (Sony). To minimize variability, four to six ve-
nules were selected in each trial and the same section of
each venule was observed throughout the experiment.
The number of rolling, adherent (attached to the vessel
wall for at least 20 s), and transmigrating leukocytes were
counted per region off-line during video playback ana-
lysis [20]. Both the surgeon and image analyzer operator
were blinded to the treatment of each animal.
Statistics
Data are expressed as mean ± standard error of mean
(SEM). Statistical analysis was performed by one-way
analysis of variance for combined data and followed by
Bonferroni’s tests. P < 0.05 was considered statistically
significant.
Experimental animals
Male Long-Evans rats (age 8 weeks) were purchased
from National Lab. Animal Breeding and Research Center
(Taipei, Taiwan). The rats were maintained in a climate
controlled facility on a 12-h light/12-h dark cycle with free
access to water and food. All experimental procedures
were conducted in accordance with the Guide for Care
and Use of Laboratory Animals and approved by the
Institutional Animal Care and Use Committee of the
Chang Gung University at Taiwan.
Results
General characteristics in Non-diabetic control, STZ-diabetic,
and insulin-treated diabetic rats
Animals treated with STZ resulted in consistent hyper-
glycemia and hypoinsulinemia that persisted over the
three-week period. At day 21 of the experiment, one
week after vehicle or insulin treatment, plasma glucose
and insulin levels in diabetic rats were 460 ± 15 mg/dl and
0.56 ± 0.07 μg/l compared with values of 125 ± 5 mg/dl
and 2.58 ± 0.36 μg/l in age-matched non-diabetic controls,
respectively (P < 0.001 and P < 0.05; Table 1). As expected,
diabetic rats had lower body weights compared with age-
matched controls (292 ± 11 vs. 391 ± 7 g, P < 0.001;
Table 1). By contrast, insulin treatment (4 IU/rat/day) for
1 week significantly attenuated diabetes-induced body
weight loss (329 ± 14 vs. 292 ± 11 g, P < 0.05), hypergly-
cemia (153 ± 10 vs. 460 ± 15 mg/dl, P < 0.001), and
hypoinsulinemia (2.04 ± 0.55 vs. 0.56 ± 0.07 μg/l, P < 0.05)
(Table 1).Insulin treatment preserved microvascular functions in
STZ-diabetic rats
The microvascular functions of cremaster muscles
were examined by intravital microscopic observation
(Figure 1A). Low rates of leukocyte adherence and trans-
migrating (1.7 ± 0.44 and 1.7 ± 0.50 numbers/100 μm,
respectively) were seen in age-matched non-diabetic
controls (Figure 1B). In the STZ-diabetic rats, a large
increase of adhering and transmigrating (6.9 ± 1.26 and
5.1 ± 0.85 numbers/100 μm, respectively) leukocytes
were observed in the postcapillary venules of the cremaster
muscle (Figure 1B). By contrast, DMI had a significantly
lower number of adhering (3.1 ± 0.60 numbers/100 μm)
and transmigrating (2.3 ± 0.46 numbers/100 μm) leuko-
cytes in the postcapillary venules of the cremaster muscle
(Figure 1B).
Diabetes increased cerebral NO level was corrected by
insulin treatment
The cerebral NO levels were also examined in control,
DM, and DMI rats (Figure 2). Under normoxic condi-
tions, the NO level in the left and right cerebral hemi-
spheres was increased in diabetic rats compared with
non-diabetic controls (Figure 2A, B). By contrast, insulin
treatment reduced NO levels compared with non-
treated diabetic rats (Figure 2A, B). The fold of the NO
level in the right to left cerebral hemispheres was no dif-
ferent among the groups (Figure 2C).
Diabetes aggravated FC I/R-induced brain infarction and
neurological deficits were rescued by insulin treatment
Hyperglycemia and insulin deficiency may have diver-
gent or distinct effects on the progression of ischemic
stroke in STZ-diabetic rats. We sought to compare dir-
ectly the severity of FC I/R-induced infarct volume and
neurological deficits (Bederson) in control, diabetic, and
insulin-treated diabetic rats. Before FC I/R injury, blood
gas parameters (PO2, PCO2, and pH) had been com-
pared and no statistical difference among the groups
Figure 1 Diabetes increased leukocyte adherence, and
transmigration in the cremasteric postcapillary venules were
corrected by insulin treatment. The numbers of adhering and
transmigrating leukocytes per high-power field were counted over
a 2-min period. Photographs are shown in A and quantified values
are shown in B. Values are expressed as mean ± SEM (n = 15 per
each group).
Figure 2 The cerebral NO levels were compared in control, DM,
and DMI rats. The left (A) and right (B) cerebral NO levels in rats
were evaluated by NO/ozone chemiluminescence technique. (C) The
ratio of right to left cerebral hemisphere NO level was also evaluated
among these groups. Results are expressed as mean ± SEM (n = 7 to 8
per each group).
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the infarct volume was 170.12 ± 14.42 mm3 in the age-
matched non-diabetic controls (n = 10). STZ-diabetic rats
indicated a dramatic enhancement of I/R-induced infarct
volume by 1.9-fold compared with non-diabetic controls(P < 0.001, n = 10). Consistent with its hypoglycemic effect,
insulin treatment significantly reduced I/R-induced in-
farct volume from 321.79 ± 29.41 to 224.91 ± 22.48 mm3
(P < 0.05, n = 10) (Figure 3A, B). For evaluation of neuro-
logical functions, Bederson tests were performed to
Figure 3 Diabetes aggravated FC I/R-induced brain infarction
and neurological deficits were rescued by insulin treatment.
The diabetic rats were induced by intravenous injection of STZ
(65 mg/kg) and then were used 2 weeks later. Insulin (4 IU rat−1 day−1)
was subcutaneously injected in STZ-diabetic rats for 1 week. Infarct
volumes were determined after 1-h focal cerebral ischemia followed
by 24-h reperfusion. Representative coronal sections (A). Mean ± SEM
of quantitative infarct volume (B). The neurological functions were
examined by Bederson score (C) in age-matched non-diabetic control
(n= 10), DM (n= 10), and insulin-treated diabetic rats (DMI, n= 10).
Values are expressed as mean ± SEM.
Hung et al. Journal of Biomedical Science 2014, 21:92 Page 5 of 9
http://www.jbiomedsci.com/content/21/1/92examine the muscle strength and postural reflex, respect-
ively. After ischemic stroke, Bederson scores were 1.5 ± 0.3
in non-diabetic control rats (Figure 3C). The FC I/R-
induced muscle strength and postural reflex weakness
were further impaired in diabetic rats (3.5 ± 0.3) as
compared with non-diabetic controls. By contrast, the
diabetic-aggravated neurological deficits were significantly
attenuated by insulin treatment (1.7 ± 0.2; Figure 3C).
General characteristics in Non-diabetic control, STZ-diabetic,
and insulin-treated diabetic rats after FC I/R injury
The characteristics of hyperglycemia and hypoinsulinemia
did not influence diabetic rats subjected to FC I/R injury.
Plasma glucose and insulin levels in diabetic rats were
508 ± 43 mg/dl and 0.61 ± 0.10 μg/l compared with values
of 194 ± 7 mg/dl and 3.07 ± 0.36 μg/l in age-matched non-
diabetic controls, respectively (P < 0.001 and P < 0.05;
Table 1) 24 hr after cerebral infarction. By contrast, insulin
treatment significantly attenuated diabetes-induced hyper-
glycemia (350 ± 51 vs. 508 ± 43 mg/dl, P < 0.05), and
hypoinsulinemia (1.66 ± 0.41 vs. 0.61 ± 0.10 μg/l, P < 0.01;
Table 1). The plasma triglyceride and cholesterol levels
were not significantly different among the groups (data
not shown).
Diabetes influenced cerebral NO, superoxide, and
peroxinitrite production in FC I/R injury was corrected
by insulin treatment
The cerebral NO, superoxide, and peroxinitrite levels
were examined in non-diabetic control, STZ-diabetic,
and insulin-treated diabetic rats subjected to FC I/R in-
jury (Figure 4). After FC I/R injury, the variability of NO
level in the contralateral cerebral hemisphere of the
groups (Figure 4A) was consistent with those rats with-
out FC I/R-injury (Figure 2A, B). However, the variability
of NO level was altered in the ipsilateral cerebral hemi-
sphere after FC I/R-injury (Figure 4B) compared with
non-FC I/R-injured right cerebral hemisphere (Figure 2B).
The fold of ipsilateral to contralateral cerebral hemisphere
NO level was significantly reduced in FC I/R-injured dia-
betic rats compared with non-diabetic controls (Figure 4C).
By contrast, insulin treatment significantly increased the
Figure 4 The cerebral NO, superoxide, and peroxynitrite levels in contralateral and ipsilateral cerebral hemisphere were compared in
control, DM, and DMI rats after FC I/R injury. The contralateral and ipsilateral cerebral hemisphere NO levels (A and B), superoxide anion
contents (D and E), and peroxynitrite production (G and H) were examined in control, DM, and DMI rats with FC I/R injury. The ratio of ipsilateral
to contralateral cerebral NO (C), superoxide (F), and peroxynitrite (I) levels was also evaluated among three groups. Results are expressed as
mean ± SEM (n = 7 to 8 per group).
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level (Figure 4C).
Among these three groups, we observed no significant
difference in the contralateral cerebral hemisphere
superoxide levels after FC I/R injury (Figure 4D). However,
superoxide level in the ipsilateral cerebral hemisphere was
significantly decreased in diabetic rats compared with age-
matched controls after FC I/R injury. Insulin treatment sig-
nificantly reversed diabetes-induced cerebral superoxide
level loss (Figure 4E). The fold of ipsilateral to contralateral
cerebral hemisphere superoxide level was significantly
reduced in FC I/R-injured diabetic rats compared with
non-diabetic controls (Figure 4F). The diabetes-induced
superoxide level decrease was significantly reversed by in-
sulin treatment (Figure 4F).
After FC I/R injury, in the contralateral cerebral hemi-
sphere, diabetes significantly reduced peroxynitrite levels
compared with non-diabetic controls, whereas treatment
with insulin showed a significantly higher peroxynitrite
levels compared with the non-treated diabetic group(Figure 4G). By contrast, peroxynitrite level in the ipsi-
lateral cerebral hemisphere was significantly increased
in diabetic rats compared with age-matched controls
after FC I/R injury. Insulin treatment significantly re-
versed diabetes-induced cerebral peroxynitrite produc-
tion (Figure 4H). Interestingly, the peroxynitrite level in
ipsilateral cerebral hemisphere was 40-fold to contra-
lateral cerebral hemisphere in STZ-diabetic rats. After
FC I/R injury, diabetic rats showed a dramatic enhance-
ment of peroxynitrite production compared with non-
diabetic controls, and the diabetes-induced peroxynitrite
level increase was significantly attenuated by insulin treat-
ment (Figure 4I).
Discussion and conclusions
The primary findings of the present study are as follows:
(1) Hyperglycemia exacerbated microvascular functions
and increased cerebral NO production. (2) Hyperglycemia
exacerbated FC I/R-induced infarct volume and neuro-
logical dysfunction. (3) Parallel with its hypoglycemic
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attenuated FC I/R injury in STZ diabetes. (4) Diabetes in-
creased NO reaction with superoxide to form peroxinitrite
in the cerebrum after FC I/R injury, and this effect was
reversed by insulin treatment.
The present study shows that diabetes increased
leukocyte adherence and transmigration in the postcapil-
lary venules of rat cremaster muscle. The cremaster
muscle is a powerful model for direct evaluation of
microvascular function in vivo. However, the influence
of diabetes on leukocyte adherence and transmigration
in the postcapillary venules of rat cremaster muscle have
yielded conflicting results. Bonnardel-Phu and Vicaut re-
ported that no difference was found in adherent leuko-
cytes or in the leukocyte rolling flux between diabetic
and normoglycemic rats [21]. In contrast, Pettersson
et al., reported that sustained hyperglycemia results in
increased levels of adherent and emigrated leukocytes in
mouse models of type 1 and type 2 diabetes [22]. In this
study, our results show the impairment of microvascular
functions in STZ diabetes. However, the administration
of insulin greatly lowered the plasma glucose level, re-
stored the microvascular dysfunction, and rescued FC I/R
injury in STZ-diabetic rats.
Oxidative stress, an imbalance between free radical
generation and elimination or detoxification, is a princi-
pal mediator of cerebral injury during ischemia and re-
perfusion. In addition, oxidative stress is known to be
involved in the development and progression of diabetes
and diabetic complications [23]. The unifying patho-
physiological mechanism that underlies ischemic stroke
in diabetes could be explained by increased production
of reactive oxygen species (ROS) and nitrogen species
(RNS) [1]. However, studies of diabetic NO levels have
yielded conflicting results [5-8]. In this study, we showed
that diabetes increased NO production which was re-
versed by insulin treatment under normoxic conditions.
A dominant paradigm to explain the increase of NO in
diabetes is that a T lymphocyte-dependent autoimmune
process activates macrophages or β-cells [24] result from
the decreased production of TGF-β1 and increased expres-
sion of iNOS pathway by macrophage. In contrast, insulin
administration to STZ-induced diabetic rodents decreases
macrophage NO production by down-regulation of the
iNOS pathway [25]. Evidence suggests that there is an in-
crease in the activity of inducible nitric oxide (iNOS) in
diabetes. The increased NO production in diabetic brain
with subsequent development of local oxidative stress is
supposed to be the possible pathophysiological mechanism
to impair endothelium-dependent relaxation of intracranial
blood vessels during STZ-induced diabetes [26]. The FC
I/R injury also increased NO production by 3.7-fold in
non-diabetic control rats. Under normoxic condition, the
fold of right to left cerebral hemisphere NO level wasnot significantly different among the groups. By contrast,
the fold of ipsilateral to contralateral cerebral hemi-
sphere NO levels was significantly reduced in FC I/
R-injured diabetic rats and treatment with insulin res-
cued the above phenomenon. These results indicate
that both diabetes and FC I/R injury increased cerebral
NO production, however, diabetes-aggravated FC I/R
injuries may be related, with loss of efficacy of the stim-
ulated NO produced. These effects were reversed by insu-
lin treatment.
Furthermore, we found that superoxide level in the ip-
silateral cerebral hemisphere and in the fold of ipsilateral
to contralateral cerebral hemisphere superoxide levels
were significantly decreased in FC I/R-injured diabetic
rats compared with non-diabetic controls. The diabetes-
induced superoxide level decrease was significantly re-
versed by insulin treatment. These results indicate that
diabetic rats reduced cerebral superoxide levels after FC
I/R injury. By contrast, insulin treatment significantly re-
versed the decrease of superoxide levels.
All ROS and RNS were previously considered toxic
agents capable of damaging biomolecules. However,
physiological free radicals superoxide and nitric oxide
are recently known to be relatively harmless species but are
able to mediate or initiate many enzyme- and gene-
dependent reactions in both physiological and pathophysio-
logical processes [27]. NO may react with superoxide to
form reactive peroxynitrite (ONOO–). Peroxynitrite is a
potent oxidizing agent that can cause DNA fragmentation
and lipid peroxidation [28]. Multiple lines of evidence dem-
onstrating the formation of peroxynitrite in diabetic vascu-
lature exist, both in experimental animals and in humans.
One of the important pathways of peroxynitrite-mediated
vascular dysfunction in diabetes involves activation of the
nuclear enzyme poly(ADP-ribose) polymerases (PARP).
Peroxynitrite-induced overactivation of PARP consumes
NAD+ and consequently ATP culminating in cell dysfunc-
tion, apoptosis, or necrosis [29].
Our results show that diabetes slight decreased super-
oxide anion production but significantly decreased per-
oxynitrite contents in the contralateral brain region.
Many studies demonstrated that endothelium-derived NO
was greatly reduced under diabetic state [30,31]. Our previ-
ous study also shows that phosphorylated eNOS protein
level was dramatic decreased in the brain of FC I/R dia-
betic rats [32]. Since peroxynitrite is formed by the NO-
superoxide reaction, reduction of superoxide anion and
endothelium-derived NO might be a possible reason for
lower peroxynitrite production in the contralateral brain
region of FC I/R diabetic rats.
In addition, we also shows that diabetes slight decreased
NO level but significantly increased peroxynitrite produc-
tion in the ipsilateral brain region of FC I/R diabetic rats.
Our previous study also shows that phosphorylated eNOS
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diabetic rats [32]. This may cause eNOS uncoupling and
consequently increase free radical production and decrease
endothelium-derived NO. Under this condition, most NO
can react with superoxide to form peroxynitrite [33].
In this study, interestingly, although the peroxinitrite
level in the contralateral cerebral hemisphere was de-
creased in diabetic rats compared with that in non-diabetic
controls after FC I/R injury and insulin significantly
rescued the phenomenon, however, the level of per-
oxynitrite in the contralateral cerebral hemisphere was
very few compared with the amount in the ipsilateral cere-
bral hemisphere. By contrast, peroxynitrite level in the ip-
silateral cerebral hemisphere and in the fold of ipsilateral
to contralateral cerebral hemisphere peroxynitrite levels
were significantly increased in diabetic rats compared with
age-matched controls after FC I/R injury. Insulin treat-
ment significantly reversed the diabetes-induced cerebral
peroxynitrite production. Interestingly, the peroxynitrite
level in ipsilateral cerebral hemisphere was 40-fold to
contralateral cerebral hemisphere in STZ-diabetic rats.
After FC I/R injury, diabetic rats showed a dramatic en-
hancement of peroxynitrite production compared with
non-diabetic controls, and the diabetes-induced peroxyni-
trite level increase was significantly attenuated by insulin
treatment.
These results indicate that diabetes stimulated NO pro-
duction and descreased superoxide production and peroxy-
nitrite formation in normoxic brain region (contralateral
brain area). However, the formation of peroxynitrite in
diabetic rats increased significantly in I/R brain region
(ipsilateral brain area) which may contribute to the prom-
inent increase in brain injury. The increase in peroxynitrite
formation and brain injury can be alleviated by insulin
treatment.
In conclusion, glycemic control with insulin treatment
may have clinical benefits for stroke patients with dia-
betes, especially in those with insulinopenic diabetes.
Our results show that NO/superoxide/peroxynitrite for-
mation and its normalization contribute to detrimental
and protective effects of diabetes and insulin, respectively,
in the context of ischemic stroke. Finally, our findings indi-
cate that insulin renders diabetic rats resistant to acute
ischemic stroke by arresting NO reaction with superoxide
to form peroxynitrite.
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